Novel therapies targeting the alternate renin angiotensin system in chronic liver disease

针对慢性肝病的替代肾素血管紧张素系统的新疗法

• 批准号: nhmrc : 1124125
• 负责人: Dr Chandana Herath
• 金额: $ 87.82万
• 依托单位: The University of Melbourne
• 依托单位国家: 澳大利亚
• 项目类别: Project Grants
• 财政年份: 2017
• 资助国家: 澳大利亚
• 起止时间: 2017-01-01 至 2021-12-31
• 项目状态: 已结题
• 来源: https://researchdata.edu.au/novel-therapies-targeting-liver-disease/947275
• 关键词: Novel; therapies; targeting; alternate; renin

Scarring of the liver due to chronic liver diseases (cirrhosis) is now a major cause of illness and death in Australia. This project will study whether drugs and gene therapy approaches targeting a hormone system called the renin angiotensin system can be used to prevent the development of cirrhosis and its complications.

在澳大利亚，慢性肝病（肝硬化）造成的肝脏疤痕现在是造成疾病和死亡的一个主要原因。该项目将研究针对肾素血管紧张素系统的激素系统的药物和基因治疗方法是否可用于预防肝硬化及其并发症的发展。